These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7622308)

  • 1. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma.
    el-Naggar AK; Lai S; Luna MA; Zhou XD; Weber RS; Goepfert H; Batsakis JG
    Int J Cancer; 1995 Jun; 64(3):196-201. PubMed ID: 7622308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene?
    Gallo O; Sardi I; Pepe G; Franchi A; Attanasio M; Giusti B; Bocciolini C; Abbate R
    Int J Cancer; 1999 Jul; 82(2):180-6. PubMed ID: 10389749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.
    Ahomadegbe JC; Barrois M; Fogel S; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
    Oncogene; 1995 Mar; 10(6):1217-27. PubMed ID: 7700647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
    Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutation is rare in oral mucosa brushings from patients previously treated for a head and neck squamous cell carcinoma.
    Acha-Sagredo A; Ruesga MT; Rodriguez C; Aguirregaviria JI; de Pancorbo MM; Califano JA; Aguirre JM
    Oral Oncol; 2009 Aug; 45(8):661-4. PubMed ID: 19027352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 gene mutations in oral carcinomas from India.
    Munirajan AK; Tutsumi-Ishii Y; Mohanprasad BK; Hirano Y; Munakata N; Shanmugam G; Tsuchida N
    Int J Cancer; 1996 May; 66(3):297-300. PubMed ID: 8621246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the p53 gene in oral squamous-cell carcinomas from Sudanese dippers of nitrosamine-rich toombak and non-snuff-dippers from the Sudan and Scandinavia.
    Ibrahim SO; Vasstrand EN; Johannessen AC; Idris AM; Magnusson B; Nilsen R; Lillehaug JR
    Int J Cancer; 1999 May; 81(4):527-34. PubMed ID: 10225439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 alterations in chemically induced hamster cheek-pouch lesions.
    Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
    Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
    Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of p53 protein is common in premalignant head and neck lesions.
    Pavelic ZP; Li YQ; Stambrook PJ; McDonald JS; Munck-Wikland E; Pavelic K; Dacic S; Danilovic Z; Pavelic L; Mugge RE
    Anticancer Res; 1994; 14(5B):2259-66. PubMed ID: 7840533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of p53 mutations increases with progression of head and neck cancer.
    Boyle JO; Hakim J; Koch W; van der Riet P; Hruban RH; Roa RA; Correo R; Eby YJ; Ruppert JM; Sidransky D
    Cancer Res; 1993 Oct; 53(19):4477-80. PubMed ID: 8402617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
    Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of mutant-type p53 expression in squamous cell carcinoma of the head and neck during radiation therapy and its clinical significance: comparison of an immunohistochemical method and PCR-SSCP assay.
    Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
    Oncol Rep; 1998; 5(5):1053-9. PubMed ID: 9683807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases.
    Tjebbes GW; Leppers vd Straat FG; Tilanus MG; Hordijk GJ; Slootweg PJ
    Oral Oncol; 1999 Jul; 35(4):384-9. PubMed ID: 10645403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutations in larynx cancer.
    Zhang LF; Hemminki K; Szyfter K; Szyfter W; Söderkvist P
    Carcinogenesis; 1994 Dec; 15(12):2949-51. PubMed ID: 8001261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
    Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
    Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.
    Chang F; Syrjänen S; Tervahauta A; Kurvinen K; Wang L; Syrjänen K
    Br J Cancer; 1994 Aug; 70(2):346-51. PubMed ID: 8054284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.
    Nylander K; Nilsson P; Mehle C; Roos G
    Br J Cancer; 1995 Apr; 71(4):826-30. PubMed ID: 7710950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
    Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG
    Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.